Overexpression of the urokinase receptor splice variant uPAR-del4/5 in breast cancer cells affects cell adhesion and invasion in a dose-dependent manner and modulates transcription of tumor-associated genes

Bettina Grismayer, Sumito Sato, Charlotte Kopitz, Christian Ries, Susanne Soelch, Manfred Schmitt, Gustavo Baretton, Achim Kruger, Thomas Luther, Matthias Kotzsch, Viktor Magdolen

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

mRNA levels of the urokinase receptor splice variant uPAR-del4/5 are associated with prognosis in breast cancer. Its overexpression in cancer cells affects tumor biologically relevant processes. In the present study, individual breast cancer cell clones displaying low vs. high uPAR-del4/5 expression were analyzed demonstrating that uPAR-del4/5 leads to reduced cell adhesion and invasion in a dose-dependent manner. Additionally, matrix metalloproteinase-9 (MMP-9) was found to be strongly upregulated in uPAR-del4/5 overexpressing compared to vector control cells. uPAR-del4/5 may thus play an important role in the regulation of the extracellular proteolytic network and, by this, influence the metastatic potential of breast cancer cells.

Original languageEnglish
Pages (from-to)1449-1455
Number of pages7
JournalBiological Chemistry
Volume393
Issue number12
DOIs
StatePublished - Dec 2012

Keywords

  • Adhesion
  • Breast cancer
  • Differential gene expression
  • Invasion
  • MMP-9
  • UPAR splice variant

Fingerprint

Dive into the research topics of 'Overexpression of the urokinase receptor splice variant uPAR-del4/5 in breast cancer cells affects cell adhesion and invasion in a dose-dependent manner and modulates transcription of tumor-associated genes'. Together they form a unique fingerprint.

Cite this